{
    "title": "AstraZeneca beats estimates on strong emerging market sales as COVID wanes",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12019809/AstraZeneca-beats-estimates-strong-emerging-market-sales-COVID-wanes.html",
    "date": "2023-04-27",
    "keywords": [
        "cancer",
        "companys",
        "quarter",
        "company",
        "grover",
        "maggie",
        "revenue",
        "imfinzi",
        "product",
        "vaccine",
        "strategy",
        "drug",
        "astrazenecas",
        "alexion",
        "year",
        "currency",
        "basis",
        "region",
        "covid",
        "london",
        "firstquarter",
        "profit",
        "treatment",
        "demand",
        "roster",
        "outlook",
        "decline",
        "height",
        "pandemic",
        "pfizer",
        "kidney",
        "rare",
        "respiratory",
        "brokerage",
        "cowen",
        "blood",
        "disorder",
        "soliris",
        "ultomiris",
        "acquisition",
        "investment",
        "director",
        "stockbroker",
        "aj",
        "bell",
        "deal",
        "couple",
        "afternoon",
        "trading",
        "period",
        "ground",
        "soriot",
        "performance",
        "covid19",
        "astrazeneca",
        "bellwether",
        "sector",
        "presence",
        "country",
        "china",
        "countrys",
        "zerocovid",
        "policy",
        "december",
        "care",
        "half",
        "growth",
        "consensus",
        "note",
        "drugmaker",
        "forecast",
        "reporting",
        "fick",
        "editing",
        "janowski",
        "shri",
        "navaratnam",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}